Chemoradiation in Cancer Therapy

图书简介

Internationally recognized experts in cancer biology and clinical research review the present status of the multimodality approach to the management of solid tumors and speculate on possible future strategies for chemoradiation therapy. The authors detail applications of combined modality therapy in lung, esophageal, breast, gastric, pancreatic, colon, and rectal cancers. They also show how radiation interacts with such chemotherapeutic agents as the platinum complexes, taxanes, and gemcitabine in the treatment of malignant gliomas, and head and neck cancer. A review of how to integrate new specific molecular targeted agents into multimodality therapy in the future.

I. General/Background.- 1 Chemoradiation: Biological Principles and Perspectives.- 2 Fluoropyrimidines as Radiation Sensitizers.- II. Mechanisms of Interaction of Specific Chemotherapeutic Agents with Radiation.- 3 The Role of Platinum Complexes in Combined Modality Therapy.- 4 Taxanes in Combined Modality Therapy.- 5 Camptothecin Radiation Sensitization.- 6 The Role of Gemcitabine in Combined Modality Therapy.- III. Clinical Applications.- 7 Chemoradiation Strategies for Patients with Malignant Gliomas.- 8 Combined Modality Strategies in the Treatment of Head and Neck Cancer.- 9 The Role of Combined Modality Therapy for Stage III Nonsmall-Cell Lung Cancer.- 10 Combined Modality Treatment of Small-Cell Lung Cancer.- 11 The Role of Chemoradiation in the Management of Esophageal Cancer.- 12 Combined Modality Therapy in Locally Advanced Breast Cancer.- 13 Combined Modality Therapy for Gastric, Pancreatic, and Biliary Tract Carcinomas.- 14 Chemoradiation in Therapy for Colon and Rectum Carcinoma.- 15 Chemoradiotherapy in Muscle-Invasive Bladder Cancer.- 16 The Role of Combined Chemotherapy and Radiation Therapy in the Treatment of Gynecologic Malignancies.- IV. Specific Molecular Targeted Agents.- 17 Overview of Specific Molecular Targeted Agents for Combined Modality Therapy.- 18 Receptor Tyrosine Kinases as Therapeutic Targets in Solid Tumors.- 19 Adenoviral p53 Gene Therapy Strategies in Nonsmall-Cell Lung Cancer.- 20 Tumor Microvasculature as a Therapeutic Target During Radiotherapy.- 21 Cancer Drug Discovery and Development: Maximizing the Therapeutic Potential of Matrix Metalloproteinase Inhibitors for the Treatment of Cancer.- 22 The Role of Cyclooxygenase-2 Inhibitors in Combined Modality Therapy.

Trade Policy 买家须知

关于产品：
● 正版保障：本网站隶属于中国国际图书贸易集团公司，确保所有图书都是100%正版。
● 环保纸张：进口图书大多使用的都是环保轻型张，颜色偏黄，重量比较轻。
● 毛边版：即书翻页的地方，故意做成了参差不齐的样子，一般为精装版，更具收藏价值。
关于退换货：
由于预订产品的特殊性，采购订单正式发订后，买方不得无故取消全部或部分产品的订购。
由于进口图书的特殊性，发生以下情况的，请直接拒收货物，由快递返回：
● 外包装破损/发错货/少发货/图书外观破损/图书配件不全（例如：光盘等）
并请在工作日通过电话400-008-1110联系我们。
签收后，如发生以下情况，请在签收后的5个工作日内联系客服办理退换货：
● 缺页/错页/错印/脱线
关于发货时间：
一般情况下：
●【现货】下单后48小时内由北京（库房）发出快递。
●【预订】【预售】下单后国外发货，到货时间预计5-8周左右，店铺默认中通快递，如需顺丰快递邮费到付。
● 需要开具发票的客户，发货时间可能在上述基础上再延后1-2个工作日（紧急发票需求，请联系010-68433105/3213）；
● 如遇其他特殊原因，对发货时间有影响的，我们会第一时间在网站公告，敬请留意。
关于到货时间：
由于进口图书入境入库后，都是委托第三方快递发货，所以我们只能保证在规定时间内发出，但无法为您保证确切的到货时间。
● 主要城市一般2-4天
● 偏远地区一般4-7天
关于接听咨询电话的时间：
010-68433105/3213正常接听咨询电话的时间为：周一至周五上午8：30～下午5：00，周六、日及法定节假日休息，将无法接听来电，敬请谅解。
其它时间您也可以通过邮件联系我们：customer@readgo.cn,工作日会优先处理。
关于快递：
● 已付款订单：主要由中通、宅急送负责派送，订单进度查询请拨打010-68433105/3213。

Chemoradiation in Cancer Therapy（Cancer Drug Discovery and Development） 肿瘤学

Chemoradiation in Cancer Therapy（Cancer Drug Discovery and Development）
肿瘤学